Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brensocatib in Severe COVID-19 (STOP-COVID19)
NCT04817332Phase 3Completed
- Sponsor
- University of Dundee
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Brensocatib Arm with Placebo Arm (2 arms). Primary endpoint: Participant Clinical Status Between Treatment Arms at 29 days. Started Jun 2020; status: completed.
02
Drugs
brensocatib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04817332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817332.